3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
18
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Leukemia, Hairy Cell
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Neoplasms
1
Anus Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Platinum
3
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Radiotherapy
2
Radiation
2
cediranib
1
atezolizumab
1
Radiotherapy, Intensity-Modulated
1
Pharmacogenomic Testing
1
Combined Modality Therapy
1
Cerebral Decortication
1
Carboplatin
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Calcium Dobesilate
×
30 days
×
Clear all
No trials found.